Literature DB >> 12588640

Unlicensed and off-label uses of drugs in paediatrics: a review of the literature.

Laura Cuzzolin1, Ada Zaccaron, Vassilios Fanos.   

Abstract

The off-label and unlicensed use of drugs to treat children is a common practice that occurs either in hospital or in the community. This derives from the fact that research for establishing drug efficacy and safety in children has not been carried out due to ethical problems, logistical difficulties, financial and legal concerns. In this work we report the studies available in literature documenting the extent of drug use in the paediatric field outside the recommendations of the license. From our analysis, a widespread attitude to prescribe medicines to children outside their product license either in the hospitals or in the community is confirmed. This suggests an immediate action for a more rationale use of drugs in paediatrics, to avoid exposing children and infants to unnecessary risks, but also to avoid depriving them of potentially effective and sometimes life-saving therapies.

Entities:  

Mesh:

Year:  2003        PMID: 12588640     DOI: 10.1046/j.1472-8206.2003.00123.x

Source DB:  PubMed          Journal:  Fundam Clin Pharmacol        ISSN: 0767-3981            Impact factor:   2.748


  22 in total

Review 1.  Dose estimation for children.

Authors:  Nigel Baber; Deborah Pritchard
Journal:  Br J Clin Pharmacol       Date:  2003-11       Impact factor: 4.335

2.  Access to children's medicines in the United Kingdom, Australia and New Zealand in 1998, 2002 and 2007.

Authors:  Rajan Ragupathy; June Tordoff; Pauline Norris; David Reith
Journal:  Pharm World Sci       Date:  2010-03-31

3.  Off label and unlicensed drugs use in paediatric cardiology.

Authors:  M Bajcetic; M Jelisavcic; J Mitrovic; N Divac; S Simeunovic; R Samardzic; R Gorodischer
Journal:  Eur J Clin Pharmacol       Date:  2005-09-08       Impact factor: 2.953

4.  Unlicensed and off-label use of medicines at a neonatology clinic in Italy.

Authors:  Maria Dell'Aera; Anna Rita Gasbarro; Margherita Padovano; Nicola Laforgia; Donatella Capodiferro; Biagio Solarino; Roberto Quaranta; Alessandro S Dell'Erba
Journal:  Pharm World Sci       Date:  2007-03-10

5.  Why were we abandoned? Orphan drugs in paediatric pain.

Authors:  Marie-Claude Grégoire; G Allen Finley
Journal:  Paediatr Child Health       Date:  2007-02       Impact factor: 2.253

6.  Patterns of Off-Label Prescribing in the Pediatric Intensive Care Unit and Prioritizing Future Research.

Authors:  Angela S Czaja; Pamela D Reiter; M Lynn Schultz; Robert J Valuck
Journal:  J Pediatr Pharmacol Ther       Date:  2015 May-Jun

Review 7.  Use of off-label and unlicenced drugs in hospitalised paediatric patients: a systematic review.

Authors:  Joana Magalhães; António Teixeira Rodrigues; Fátima Roque; Adolfo Figueiras; Amílcar Falcão; Maria Teresa Herdeiro
Journal:  Eur J Clin Pharmacol       Date:  2014-10-16       Impact factor: 2.953

8.  Is puberty delaying treatment 'experimental treatment'?

Authors:  Simona Giordano; Søren Holm
Journal:  Int J Transgend Health       Date:  2020-04-11

9.  Off-label drug use in children.

Authors:  Surabhi S Jain; S B Bavdekar; Nithya J Gogtay; Pranjali A Sadawarte
Journal:  Indian J Pediatr       Date:  2008-09-22       Impact factor: 1.967

10.  Drug utilization and off-label drug use among Spanish emergency room paediatric patients.

Authors:  Cristina Morales-Carpi; Luis Estañ; Elena Rubio; Empar Lurbe; Francisco J Morales-Olivas
Journal:  Eur J Clin Pharmacol       Date:  2010-03       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.